Clinical and Histological Evaluation of Zimmer Puros® Allograft vs. Creos™ (Low-cost) Allograft for Alveolar Ridge Preservation Following Exodontia
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 15
- 试验地点
- 2
- 主要终点
- Cone beam computed tomography bone density changes
研究概览
简要总结
The purpose of this study is to evaluate clinically, histologically and radiographically the healing of extraction sockets with Zimmer's Puros® allograft compared to creos™ (creo™ Nobel Biocare,), a low-cost allograft material, 90 days following exodontia.
详细描述
Twenty-four consecutive subjects requiring extraction of two non-adjacent molars or premolars located in the same jaw will be selected from the patient pool of the Center for Advanced Periodontology at the University of Florida, College of Dentistry.
Preoperative Procedures: At the initial screening, the goals of the study, potential risks and possible benefits will be explained and each subject will be asked to sign a written consent statement permitting extraction of the involved teeth and the placement of Puros® allograft and creos™ allograft for ridge preservation. After which a complete medical and dental history will be obtained, a pregnancy test will be performed, and establishment of inclusion and exclusion criteria will be determined. If meeting all study criteria, examination periapical radiographs will be taken and each subject will receive oral hygiene instructions, prophylaxis, and full-arch alginate impressions. The study models will also be used to fabricate occlusal templates to permit reproducible clinical measurements of the alveolar ridge dimensions of the residual tooth socket.
Surgical Protocol & Treatment Assessment: To help minimize technical variances in the surgical treatment protocol, the primary investigator will perform baseline and 12-week re-entry surgeries. Under local anesthesia, full-thickness mucoperiosteal flaps will be elevated; the selected teeth will be extracted atraumatically, followed by debridement of the sockets, and collection of all clinical measurements.The following clinical measurements will be made at the baseline and re-entry surgeries using standard University of North Carolina (UNC) manual probes (Hu-Friedy, Chicago, IL):
- Facial/buccal thickness (baseline, only)
- Distance from the occlusal template to the facial, lingual and crestal bone
- Socket depth (or template to crest distance at the 90-day re-entry surgery)
- Osseous dehiscence location and dimension
- Bone density (on re-entry)
The surgeon will then preserve each site with either Puros® allograft creos™ allograft. Puros® allograft will be placed into half of the extraction sockets to the level of the osseous crest. A bovine pericardium membrane (CopiOs ®Pericardium) will be then placed to cover the bone graft material. Primary closure will be achieved in all cases. The site will be sutured with 4.0 PTFE sutures. The other extraction sites will receive the same treatment but with creos™ allograft. Participants will be prescribed a 10 day regimen of Ibuprofen (2.4g/day) and antibiotics (amoxicillin (1.5g/day) or clindamycin (0.6g/day)) unless other allergies are present. Subjects will be instructed to change their diet to semi-liquid for 48 hours, followed by soft foods for the first 2-weeks. Subjects will also be instructed to begin rinsing with warm water, as needed, and to resume their normal oral hygiene routine the day after surgery in all areas except the surgical site.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 21 Years 至 75 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Systemically healthy subjects with two non-adjacent molar or premolar teeth located in the same jaw that require extraction and socket augmentation for implant site development (treatment sites may be located in either the mandibular or maxillary jaw)
- •Residual extraction sockets must have <70% bone loss in all dimensions (3 or 4-walled bony defects)
- •Nonsmokers (individuals who quit smoking at least 6 months prior to the study will be allowed to participate)
- •Subjects willing and able to comply with all study-related procedures including maintenance of good oral hygiene and compliance with re-evaluation appointments
- •Subjects who read, understand and are willing to sign an informed consent statement.
排除标准
- •Inadequate zone of keratinized gingiva (KG) or alveolar mucosa to obtain primary wound closure of the surgical site
- •Presence of acute infections at the time of tooth extraction
- •Clinically significant or unstable (as defined by the investigators) systemic diseases affecting bone or soft tissue growth; or other renal, hepatic, cardiac, endocrine, hematologic, autoimmune or acute infectious diseases that makes interpretation of the data more difficult
- •History of head & neck radiation therapy
- •Subjects taking steroids, tetracycline or tetracycline analogs, bone therapeutic levels of fluorides, biphosphonates, medications affecting bone turnover, antibiotics for >7 days or any investigational drug
- •Patients who are or become pregnant during the length of the study.
研究组 & 干预措施
Zimmer Puros Cancellous Allograft
Right side will have an extraction followed by an allogenic bone graft zimmer puros followed by implant placement.
干预措施: Zimmer Puros Cancellous Allograft (Device)
Nobel Biocare Creos Cancellous Allograft
Left side will have an extraction followed by an allogenic bone nobel biocare creos graft followed by implant placement.
干预措施: Nobel Biocare Creos Cancellous Allograft (Device)
结局指标
主要结局
Cone beam computed tomography bone density changes
时间窗: At week 12
Percentage of volumetric bone formation observed by comparison of Cone beam computed tomography images and the percentage of residual Puros® bone cores
时间窗: At week 12
Percentage of volumetric bone formation observed by comparison of Cone beam computed tomography images and the percentage of residual creos™ allograft in the bone cores
时间窗: At week 12
Bone change in millimeters from initial (baseline) to full healing (week 12)
时间窗: At week 12
Percentage of bone formation in the alveolar bone core biopsies
时间窗: At week 12
次要结局
- Facial/buccal alveolar bone thickness measured in millimeters with calipers(At Baseline)
- Width of alveolar dehiscence defects measured in millimeters with a periodontal probe(At Baseline)
- Plaque score(Pre-op, Baseline, Week 2, 8 and 12)
- Length of alveolar dehiscence defects measured in millimeters with a periodontal probe(At Baseline)
- Subjective clinical bone density on re-entry(At week 12)
